Amgen AMGN
NASDAQ AMGN
$438.79 +7.58 (+1.76%)
As of: Aug 21, 2026 · 1:13 PM EDT

Amgen (AMGN) Short term Debt (2009 - 2026)

Amgen (AMGN) posted quarterly Short term Debt of $5.4 billion for Q1 2026, up 61.43% year-over-year from $3.4 billion in Q1 2025, and up 18.22% quarter-over-quarter from $4.6 billion in Q4 2025.

Amgen (AMGN) Short term Debt (2009 - 2026) Analysis & Trends

Amgen's Short term Debt history runs 16 years deep, the most recent figure standing at $5.4 billion for Q1 2026.

  • In Q1 2026, Short term Debt rose 61.43% year-over-year to $5.4 billion; the TTM figure through Mar 2026 stood at $5.4 billion (up 61.43% YoY), while the FY2025 annual figure was $4.6 billion, up 29.55% from the prior year.
  • Short term Debt for Q1 2026 stood at $5.4 billion, up from $4.6 billion in the prior quarter.
  • The five-year high for Short term Debt was $5.5 billion in Q2 2024, with the low at $817.0 million in Q2 2022.
  • The 5-year median for Short term Debt is $2.2 billion (2023), against an average of $2.7 billion.
  • Peak annual rise in Short term Debt reached 1728.74% in 2022, while the deepest fall reached 81.11% in 2022.
  • Amgen's Short term Debt stood at $1.6 billion in 2022, then retreated by 9.3% to $1.4 billion in 2023, then surged by 146.02% to $3.6 billion in 2024, then grew by 29.55% to $4.6 billion in 2025, then advanced by 18.22% to $5.4 billion in 2026.
  • Business Quant data shows AMGN's Short term Debt at $5.4 billion in Q1 2026, $4.6 billion in Q4 2025, and $2.2 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.29 Bn 631.53 Bn 17.26 Bn
2 AbbVie 470.62 Bn 464.06 Bn 12.70 Bn
3 Merck 375.66 Bn 368.52 Bn 12.21 Bn
4 Novartis Ag 302.90 Bn 295.21 Bn 11.24 Bn
5 Astrazeneca 257.50 Bn 252.60 Bn 12.86 Bn
6 Amgen 237.19 Bn 223.20 Bn 7.24 Bn
7 Gilead Sciences 182.92 Bn 179.74 Bn 6.22 Bn
8 Pfizer 160.14 Bn 148.44 Bn 10.94 Bn
9 Gsk 106.08 Bn 101.91 Bn 8.24 Bn
10 Sanofi 55.22 Bn 47.84 Bn 10.79 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 5.45 Bn
Mar 31, 2026 5.44 Bn
Dec 31, 2025 4.60 Bn
Sep 30, 2025 2.15 Bn
Jun 30, 2025 2.44 Bn
Mar 31, 2025 3.37 Bn
Dec 31, 2024 3.55 Bn
Sep 30, 2024 3.54 Bn
Jun 30, 2024 5.53 Bn
Mar 31, 2024 3.96 Bn
Dec 31, 2023 1.44 Bn
Sep 30, 2023 1.43 Bn
Jun 30, 2023 2.17 Bn
Mar 31, 2023 834.00 Mn
Dec 31, 2022 1.59 Bn
Sep 30, 2022 1.54 Bn
Jun 30, 2022 817.00 Mn
Mar 31, 2022 844.00 Mn
Dec 31, 2021 87.00 Mn
Sep 30, 2021 4.29 Bn